Arthur Thomas Suckow
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$1.5MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $1.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 7, 2021 | NIH | STTR Phase I Reversal of Tau Pathology with MSUT2 siRNA Conjugates | $100K | DTx Pharma, Inc. |
| Sep 19, 2020 | NIH | SBIR Phase I Development of PMP22 siRNA Conjugates for Treatment of Charcot-Marie-Tooth Disease Type 1A | $388K | DTx Pharma, Inc. |
| Aug 17, 2020 | NIH | STTR Phase I Reversal of Tau Pathology with MSUT2 siRNA Conjugates | $213K | DTx Pharma, Inc. |
| Sep 11, 2019 | NIH | SBIR Phase I Generation of potent, safe and deliverable human Tau targeting siRNA for treatment of Tauopathies | $225K | DTx Pharma, Inc. |
| Apr 2, 2019 | NIH | SBIR Phase I Systemic Characterization of Novel Lipidated siRNA Conjugates | $322K | DTx Pharma, Inc. |
| Apr 2, 2019 | NIH | SBIR Phase I Development of Conjugated Oligonucleotide Therapeutics for Neuronal Disease | $301K | DTx Pharma, Inc. |
Peer ranks
Federal funding#1,324
Awards as PI#315
Patents#273
Companies
- DTx Pharma, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.